Found: 127
Select item for more details and to access through your institution.
Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Risk Factor Analysis for Anti-epidermal Growth Factor Receptor Monoclonal Antibody-induced Problematic Skin Toxicities in Patients With Liver Metastatic Colorectal Cancer.
- Published in:
- In Vivo, 2024, v. 38, n. 5, p. 2390, doi. 10.21873/invivo.13706
- By:
- Publication type:
- Article
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1011, doi. 10.1007/s10637-022-01285-9
- By:
- Publication type:
- Article
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
- By:
- Publication type:
- Article
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 740, doi. 10.1007/s10637-014-0154-x
- By:
- Publication type:
- Article
Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 473, doi. 10.1007/s10637-013-0056-3
- By:
- Publication type:
- Article
Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 1950, doi. 10.1007/s10637-011-9751-0
- By:
- Publication type:
- Article
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 787, doi. 10.1007/s10637-010-9615-z
- By:
- Publication type:
- Article
Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 6, p. 866, doi. 10.1007/s10637-009-9306-9
- By:
- Publication type:
- Article
Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 01, doi. 10.3389/fcimb.2022.925444
- By:
- Publication type:
- Article
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 53, doi. 10.1007/s40261-020-00979-3
- By:
- Publication type:
- Article
Modified-Irinotecan/Fluorouracil/ Levoleucovorin Therapy as Ambulatory Treatment for Metastatic Colorectal Cancer.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 4, p. 243, doi. 10.2165/11534470-000000000-00000
- By:
- Publication type:
- Article
TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 3, p. 327, doi. 10.1016/j.clcc.2023.06.001
- By:
- Publication type:
- Article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 207, doi. 10.1159/000512820
- By:
- Publication type:
- Article
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10403-y
- By:
- Publication type:
- Article
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10403-y
- By:
- Publication type:
- Article
Optimal Dose Period for Indisetron Tablets for Preventing Chemotherapy-Induced Nausea and Vomiting with Modified FOLFOX6: A Randomized Pilot Study.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 439, doi. 10.1159/000345920
- By:
- Publication type:
- Article
Anti-epidermal growth factor receptor treatment for patients with Neo RAS wild-type metastatic colorectal cancer: a case report of two cases.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231216090
- By:
- Publication type:
- Article
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 283, doi. 10.1038/s41416-024-02730-7
- By:
- Publication type:
- Article
Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 296, doi. 10.1007/s12325-021-01931-3
- By:
- Publication type:
- Article
Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 7, p. 483, doi. 10.1007/s12325-010-0037-2
- By:
- Publication type:
- Article
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 5, p. 956, doi. 10.1007/s10120-022-01310-z
- By:
- Publication type:
- Article
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
- By:
- Publication type:
- Article
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 118, doi. 10.1007/s10120-019-00966-4
- By:
- Publication type:
- Article
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 817, doi. 10.1007/s10120-018-0903-1
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 429, doi. 10.1007/s10120-017-0773-y
- By:
- Publication type:
- Article
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 927, doi. 10.1007/s10120-015-0559-z
- By:
- Publication type:
- Article
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
- By:
- Publication type:
- Article
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 2, p. 175, doi. 10.1007/s10120-012-0167-0
- By:
- Publication type:
- Article
Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 719, doi. 10.1159/000507814
- By:
- Publication type:
- Article
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
- Published in:
- Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624
- By:
- Publication type:
- Article
Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302).
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 70, doi. 10.1159/000328739
- By:
- Publication type:
- Article
Pilot Study of Combination Chemotherapy Using Irinotecan plus S-1 for Metastatic Pancreatic Cancer.
- Published in:
- Oncology, 2008, v. 75, n. 1/2, p. 67, doi. 10.1159/000151742
- By:
- Publication type:
- Article
Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 647, doi. 10.1007/s10147-024-02488-1
- By:
- Publication type:
- Article
Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1183, doi. 10.1007/s10147-023-02364-4
- By:
- Publication type:
- Article
Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 11, p. 1780, doi. 10.1007/s10147-022-02235-4
- By:
- Publication type:
- Article
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2025, doi. 10.1007/s10147-021-02004-9
- By:
- Publication type:
- Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
- By:
- Publication type:
- Article
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 10, p. 1800, doi. 10.1007/s10147-020-01720-y
- By:
- Publication type:
- Article